Low concentration of topical cyclosporin A for severe alopecia areata

P. D. Pigatto, M. M. Montalbano, R. Cirillo, N. Mozzanica, G. F. Altomare, A. F. Finzi

Research output: Contribution to journalArticlepeer-review

Abstract

The results of a trial on 59 patients with severe alopecia areata involving more than 30% of the scalp are reported. Topical 0.2% cyclosporin A treatment appears to be more useful than placebo and in addition has no relevant side effects. Cyclosporin A appeared to be a reasonable therapeutic option for severe alopecia areata even though a recurrence cannot yet be prevented, so that the follow-up at 6 to 12 months showed no differences between treatment and placebo.

Original languageEnglish
Pages (from-to)377-382
Number of pages6
JournalAnnali Italiani di Dermatologia Clinica e Sperimentale
Volume42
Issue number4
Publication statusPublished - 1988

ASJC Scopus subject areas

  • Dermatology

Fingerprint

Dive into the research topics of 'Low concentration of topical cyclosporin A for severe alopecia areata'. Together they form a unique fingerprint.

Cite this